SMARCA4 and cancer: Given the critical role of glutaminolysis for sustaining the TCA cycle in SMARCA4/2-deficient cancer cells, we hypothesized that they are sensitive to the inhibition of glutaminase, which catalyzes the conversion of glutamine to glutamate (Fig. 4c), the first step in glutamine metabolism53.